“CLOTURE MOTION” published by Congressional Record in the Senate section on March 9

0Comments

Volume 167, No. 44, covering the 1st Session of the 117th Congress (2021 – 2022), was published by the Congressional Record.

The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.

“CLOTURE MOTION” mentioning Christopher A. Coons was published in the Senate section on pages S1420-S1421 on March 9.

Of the 100 senators in 117th Congress, 24 percent were women, and 76 percent were men, according to the Biographical Directory of the United States Congress.

Senators’ salaries are historically higher than the median US income.

The publication is reproduced in full below:

CLOTURE MOTION

The PRESIDING OFFICER. Pursuant to rule XXII, the Chair lays before the Senate the pending cloture motion, which the clerk will state.

The legislative clerk read as follows

Cloture Motion

We, the undersigned Senators, in accordance with the provisions of rule XXII of the Standing Rules of the Senate, do hereby move to bring to a close debate on the nomination of Executive Calendar No. 12, Marcia Louise Fudge, of Ohio, to be Secretary of Housing and Urban Development.

Charles E. Schumer, Sherrod Brown, Richard Blumenthal,

Christopher A. Coons, Patty Murray, Chris Van Hollen,

Sheldon Whitehouse, Jeff Merkley, Brian Schatz, Cory A.

Booker, Amy Klobuchar, Benjamin L. Cardin, Angus S.

King, Jr., Kirsten E. Gillibrand, Tim Kaine, Tammy

Baldwin.

The PRESIDING OFFICER. By unanimous consent, the mandatory quorum call has been waived.

The question is, Is it the sense of the Senate that debate on the nomination of Marcia Louise Fudge, of Ohio, to be Secretary of Housing and Urban Development, shall be brought to a close?

The yeas and nays are mandatory under the rule.

The clerk will call the roll.

The legislative clerk called the roll.

Mr. THUNE. The following Senator is necessarily absent: the Senator from North Dakota (Mr. Cramer).

The yeas and nays resulted–yeas 69, nays 30, as follows:

YEAS–69

BaldwinBennetBlumenthalBluntBookerBraunBrownCantwellCapitoCardinCarperCaseyCollinsCoonsCortez MastoDuckworthDurbinFeinsteinGillibrandGrahamGrassleyHassanHeinrichHickenlooperHironoHoevenInhofeJohnsonKaineKellyKingKlobucharLeahyLujanManchinMarkeyMarshallMcConnellMenendezMerkleyMoranMurkowskiMurphyMurrayOssoffPadillaPetersPortmanReedRomneyRosenRoundsSandersSchatzSchumerScott (SC)ShaheenSinemaSmithStabenowSullivanTesterVan HollenWarnerWarnockWarrenWhitehouseWydenYoung

NAYS–30

BarrassoBlackburnBoozmanBurrCassidyCornynCottonCrapoCruzDainesErnstFischerHagertyHawleyHyde-SmithKennedyLankfordLeeLummisPaulRischRubioSasseScott (FL)ShelbyThuneTillisToomeyTubervilleWicker

NOT VOTING–1

Cramer

The PRESIDING OFFICER (Mr. Peters). The yeas are 69, the nays are 30.

=========================== NOTE ===========================

On page S1421, March 9, 2021, first column, the following appears: The PRESIDING OFFICER (Mr. Peters). The nays are 69, the nays are 30.

The online Record has been corrected to read: The PRESIDING OFFICER (Mr. Peters). The yeas are 69, the nays are 30.

========================= END NOTE =========================

The motion is agreed to.

____________________

SOURCE: Congressional Record Vol. 167, No. 44



Related

John T. Dorsey Chief Judge at U.S. Bankruptcy Court for the District of Delaware

Judge John T. Dorsey remembered after passing following battle with cancer

Judge John T. Dorsey has passed away following a battle with cancer, according to an announcement from the U.S. Bankruptcy Court for the District of Delaware on Apr. 15. He served as Chief Judge from 2024-2025 and had a long career dedicated to public service.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA inspection: Which types of Delaware companies faced the most scrutiny in March?

The U.S. Food and Drug Administration (FDA) carried out inspections at two food and cosmetics companies in Delaware during March.

Benjamin D. Moncarz Chief Financial Officer - FDA

Device companies saw the fewest FDA inspections in Delaware in 2025

The U.S. Food and Drug Administration (FDA) carried out an inspection at a device manufacturer in Delaware in 2025.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.